Testing effectiveness (Phase 2)Study completedNCT01235117What this trial is testingAzacitidine in Treating Patients With Chronic Myelomonocytic LeukemiaWho this might be right forLeukemia University of Leeds 30
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06059391What this trial is testingCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more City of Hope Medical Center 216
Testing effectiveness (Phase 2)Looking for participantsNCT07269470What this trial is testingPhase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseWho this might be right forChronic Myeloid Leukemia M.D. Anderson Cancer Center 40
Early research (Phase 1)WithdrawnNCT00866346What this trial is testingPR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic TransplantationWho this might be right forChronic Myelogenous Leukemia M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01093586What this trial is testingDonor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more Case Comprehensive Cancer Center 14
Not applicableStudy completedNCT00899015What this trial is testingAssessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070JWho this might be right forLeukemiaLymphoma National Institutes of Health Clinical Center (CC) 23
Not applicableLooking for participantsNCT01137825What this trial is testingRegistry of Older Patients With CancerWho this might be right forChronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more UNC Lineberger Comprehensive Cancer Center 3,000
Testing effectiveness (Phase 2)Study completedNCT01244906What this trial is testingPost-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) TransplantWho this might be right forHematologic Neoplasms Northside Hospital, Inc. 26
Testing effectiveness (Phase 2)UnknownNCT02511340What this trial is testingA Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP PatientsWho this might be right forChronic Myelogenous Leukemia Jiangsu Hansoh Pharmaceutical Co., Ltd. 167
Large-scale testing (Phase 3)Study completedNCT00438958What this trial is testingSibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more The Canadian Blood and Marrow Transplant Group 230
Early research (Phase 1)Study completedNCT03746041What this trial is testingA Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic SyndromesWho this might be right forMyelodysplastic SyndromesChronic Myelomonocytic Leukemia University of Rochester 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05038592What this trial is testingPhase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic SyndromesWho this might be right forChronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+1 more M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT03674411What this trial is testingTrial Evaluating MGTA-456 in Patients With High-Risk MalignancyWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaBiphenotypic/Undifferentiated Leukemia+8 more Masonic Cancer Center, University of Minnesota 22
Testing effectiveness (Phase 2)Study completedNCT00053196What this trial is testingDonor Stem Cell Transplant in Treating Patients With Relapsed Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma+3 more Alliance for Clinical Trials in Oncology 82
Testing effectiveness (Phase 2)Study completedNCT01445080What this trial is testingSorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LeukemiaWho this might be right forBlastic PhaseChildhood Acute Promyelocytic Leukemia With PML-RARAChildhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive+7 more National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00674479What this trial is testingINCB018424 in Patients With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome+1 more M.D. Anderson Cancer Center 51
Early research (Phase 1)Study completedNCT01344707What this trial is testingOral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)Who this might be right forAdvanced Hematologic Malignancies 4SC AG 36
Testing effectiveness (Phase 2)Study completedNCT00049634What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative DisorderWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT00428909What this trial is testingEffect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)Who this might be right forChronic Myeloid Leukemia (CML) Novartis Pharmaceuticals 12